Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 Next Page Last Page
 
1
Services to Operate a Hemoglobin Production Facility and a Red Blood Cell Storage Laboratory.
1995-01-01

A research laboratory to support red blood cell preservation research, a facility to manufacture acellular hemoglobin solution and a quality control laboratory to support the hemoglobin production were established at the Blood Research Detachment, 1413 Re...

National Technical Information Service (NTIS)

2
KINRIX� (Diphtheria and Tetanus Toxoids and Acellular Pertussis ...

... Product: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine; KINRIX FDA STN: 125260 ...

Center for Biologics Evaluation and Research (CBER)

3
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis ...

... US. -. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. -. Products. Adacel Sanofi Pasteur, Ltd. ...

Center for Biologics Evaluation and Research (CBER)

4
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed ...

... Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine. -. Product. Kinrix. -. Contact Us. Consumer Affairs Branch ( ...

Center for Biologics Evaluation and Research (CBER)

5
Heparin-Chitosan-Coated Acellular Bone Matrix Enhances Perfusion of Blood and Vascularization in Bone Tissue Engineering Scaffolds.
2011-06-20

Currently, the main hurdle in the tissue engineering field is how to provide sufficient blood supply to grafted tissue substitutes in the early post-transplanted period. For three-dimensional, cell-dense, thick tissues to survive after transplantation, treatments are required for hypoxia, nutrient insufficiency, and the accumulation of waste products. In ...

PubMed

6
Pentacel - Diphtheria and Tetanus Toxoids and Acellular Pertussis ...

... The mixture of these purified and inactivated polioviruses is used for production by Sanofi Pasteur (SP) of two IPV products: IPOL® (virus grows on Monkey ...

Center for Biologics Evaluation and Research (CBER)

7
Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
2011-03-23

The development of artificial oxygen carriers has attracted considerable recent interest because of the increasing cost of collecting and processing blood, public concerns about the safety of blood products, complications from blood transfusions, military requirements for increased volumes of ...

PubMed

8
Blood Products Advisory Committee

... Resources for You. Blood & Blood Products. -. Blood Products Advisory Committee. The Blood Products Advisory Committee (BPAC) reviews ...

Center for Biologics Evaluation and Research (CBER)

9
Acellular extracellular matrix anal fistula plug: results in high fistula-in-ano awaited.
2008-12-14

Song et al have reported a 100% success rate of acellular extracellular matrix (AEM) anal fistula plug in low fistula-in-ano. The results with this product in high fistula-in-ano are keenly awaited. PMID:19084926

PubMed

10
Acellular extracellular matrix anal fistula plug: Results in high fistula-in-ano awaited
2008-12-14

Song et al have reported a 100% success rate of acellular extracellular matrix (AEM) anal fistula plug in low fistula-in-ano. The results with this product in high fistula-in-ano are keenly awaited.

PubMed Central

11
Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age
2007-07-01

OBJECTIVEThe safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b (DTaP-IPV-Hib [Pediacel, sanofi pasteur, Canada]) were assessed and compared with that of Hib vaccine ...

PubMed Central

12
Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, Vol. 55, No. RR-3, March 24, 2006.
2006-01-01

During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in adults) were licensed in the United States (BOOSTRIX, GlaxoSmithKline Biologi...

National Technical Information Service (NTIS)

13
Using a synthetic body fluid (SBF) solution of 27 mM HCO3

(SBF) solution, mimicking the human blood plasma, with the following ion concentrations of 27 mM HCO3 cements doped with CaHPO4 (monetite), were shown to have apatite-inducing ability upon ageing in Tris development of synthetic or simulated body fluids (SBF, which claim to mimic the acellular human blood plasma

E-print Network

14
Advanced glycation end products and diabetic retinopathy.
2011-09-11

Retinopathy is a serious microvascular complication of diabetes and a major cause of blindness in young adults, worldwide. Early diabetic retinopathy is characterized by a loss of pericytes from retinal capillaries, the appearance of acellular capillaries and microaneurysms, and a breakdown of the blood-retinal barrier. In later stages, this can evolve ...

PubMed

15
Allylation of Intraerythrocytic Hemoglobin by Raw Garlic Extracts
2010-08-01

AbstractRecent studies have shown that deoxygenated human red blood cells (RBCs) converted garlic-derived polysulfides into hydrogen sulfide, which in turn produced vasorelaxation in aortic ring preparations. The vasoactivity was proposed to occur via glucose- and thiol-dependent acellular reactions. In the present study, we investigated the interaction of ...

PubMed Central

16
Aldose reductase / polyol inhibitors for diabetic retinopathy.
2011-03-01

Diabetic retinopathy is the most common microvascular complication of diabetes and the most severe of diabetic ocular complications. This review describes retinal changes at different stages of diabetic retinopathy and risk factors associated with this devastating disease. Special attention is focused on aldose reductase, the first enzyme of the sorbitol pathway of glucose metabolism. The current ...

PubMed

17
21 CFR 207.7 - Establishment registration and product listing for human blood and blood products and for medical...
2011-04-01

...Establishment registration and product listing for human blood and blood products and for medical devices. 207.7 Section...Establishment registration and product listing for human blood and blood products and for medical ...

Code of Federal Regulations, 2011

18
Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants.
2011-07-01

To examine the influence of a pertussis booster vaccination on the transfer of maternal antibodies, 24 nonpregnant women received a tetanus, diphtheria, acellular pertussis booster vaccine between 2 consecutive pregnancies. Blood was drawn from mothers and off-spring. Efficient transplacental antibody transfer and significantly higher antibody titers ...

PubMed

19
BK080006 - IntelliDOT Blood Product Administration

... label matches the information that is on the blood product tag prior to attaching the blood product tag to a blood product bag c. Assisting nursing personal to ...

Center for Biologics Evaluation and Research (CBER)

20
The pro-myogenic environment provided by whole organ scale acellular scaffolds from skeletal muscle.
2011-07-30

In the pursuit of a transplantable construct for the replacement of large skeletal muscle defects arising from traumatic or pathological conditions, several attempts have been made to obtain a highly oriented, vascularized and functional skeletal muscle. Acellular scaffolds derived from organ decellularization are promising, widely used biomaterials for tissue engineering. ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
21
Mathematical Model of NO and O2 Transport in an Arteriole Facilitated by Hemoglobin Based O2 Carriers
2009-02-21

The increasing demand for donated human blood has spurred research to develop hemoglobin-based O2 carriers (HBOCs) that can be used as red blood cell (RBC) substitutes. However, in vivo studies of acellular HBOCs have shown an increase in mean arterial pressure following transfusion that has been attributed to ...

PubMed Central

22
Actions Needed to Stop Excess Medicare Payments for Blood and Blood Products.
1979-01-01

Billing and replacement practices of blood banks and hospitals have caused substantial Medicare overpayments for blood and blood products. Blood banks have prevented the use of blood replacement credits to reduce blood fees whenever Medicare would pay ...

National Technical Information Service (NTIS)

23
Improving the Safety of Blood and Blood Related Products by ...

... Vaccines, Blood & Biologics. ... Improving the Safety of Blood and Blood Related Products by Reducing the Risk of Transfusion-Transmission of Leishmania Parasites. ...

Center for Biologics Evaluation and Research (CBER)

24
Blood Research

... Vaccines, Blood & Biologics. ... Blood Research. -. ... Studies on Safety and Efficacy of Platelets and Other Transfused Blood Products Jaroslav Vostal, MD; ...

Center for Biologics Evaluation and Research (CBER)

25
Blood & Blood Products

... the blood industry: FDA inspects all blood facilities at least every two years, and "problem" facilities are inspected more often. ...

Center for Biologics Evaluation and Research (CBER)

26
Acellular dermal matrix in breast reconstruction in the setting of radiotherapy.
2011-09-01

Acellular dermal matrices (ADM) are becoming an integral component of immediate implant-based breast reconstruction, providing inferolateral coverage and support of the implant. Currently, five ADM products are available on the market for this purpose. Although their application has resulted in improved aesthetic results with low complication rates, the ...

PubMed

27
Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan.
2001-10-01

Diphtheria tetanus acellular pertussis combined (DTaP) vaccines have been successfully used in Japan by controlling their potencies and toxicities with animal models. In accordance with the recent practical introduction of DTaP vaccines of various formulations, a question has been raised in other nations as to the efficacy of a quality control system based on animal tests and ...

PubMed

28
Abdominal ventral hernia repair with current biological prostheses: an experimental large animal model.
2011-04-01

Biologic prostheses have emerged to address the limitations of synthetic materials for ventral hernia repairs; however, they lack experimental comparative data. Fifteen swine were randomly assigned to 1 of 3 bioprosthetic groups (DermaMatrix, AlloDerm, and Permacol) after creation of a full thickness ventral fascial defect. At 15 weeks, host incorporation, hernia recurrence, adhesion formation, ...

PubMed

29
Spleen (image)

The spleen is an organ involved in the production and maintenance of red blood cells, the production of certain circulating white blood cells, ...

MedlinePLUS

30
Guidance for Industry

... derivative productsBlood and blood components6 � Gene therapy products � Somatic cellular therapy products (including xenotransplantation products). ...

Center for Biologics Evaluation and Research (CBER)

31
21 CFR 607.37 - Inspection of establishment registrations and blood product listings.
2011-04-01

... true Inspection of establishment registrations and blood product listings. 607.37 Section 607.37 Food...REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS Procedures for Domestic Blood ...

Code of Federal Regulations, 2011

32
21 CFR 607.25 - Information required for establishment registration and blood product listing.
2011-04-01

...Information required for establishment registration and blood product listing. 607.25 Section 607.25 Food...REGISTRATION AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS Procedures for Domestic Blood ...

Code of Federal Regulations, 2011

33
Blood Donors and the Supply of Blood and Blood Products: Forum on Blood Safety and Blood Availability.
1996-01-01

The Forum on Blood Safety and Blood Availability was convened by the Institute of Medicine in 1994 to provide an environment within which representatives of blood banking and transfusion medicine, the Food and Drug Administration and other government agen...

National Technical Information Service (NTIS)

34
Biological Product Deviation Reporting - Blood Product Codes

... Biological Product Deviation Reporting - Blood Product Codes. DB01 - Whole Blood DB05 - Cryoprecipitated AHF DB06 ...

Center for Biologics Evaluation and Research (CBER)

35
Revised Guideline for Collection of Blood or Blood Products from ...

... Subject: Revision to 26 October 1989 Guideline for Collection of Blood or Blood Products from Donors with Positive Tests for Infectious Disease Markers ("High ...

Center for Biologics Evaluation and Research (CBER)

36
Production and secretion of pertussis toxin subunits in Bacillus subtilis.
1990-03-01

Pertussis toxin (PT) is a major component of today's acellular whooping cough vaccines. The use of acellular vaccines is predicted to increase sharply in the near future. There is therefore a need to produce PT in a way that makes its purification as easy as possible. Our approach was to express all five PT subunits individually in Bacillus subtilis. We ...

PubMed

37
Acellular dermal matrix: general principles for the plastic surgeon.
2011-09-01

Acellular dermal matrix (ADM) is a recently-developed, biologically-derived product with many useful applications in plastic surgery, in both cosmetic and reconstructive procedures. While the use of ADM initially outpaced quality literature, within the past 10 years the literature on ADM has rapidly expanded. Some of these data show promising results in ...

PubMed

38
Blood Service Delivery Network in the United States and Dallas County: A Background Paper.
1979-01-01

The blood service delivery system in the United States and in Dallas County, Texas, is examined. The composition and specific uses of blood are considered. Blood products include whole blood and a variety of forms of red blood cells. Five types of blood ...

National Technical Information Service (NTIS)

39
21 CFR 640.14 - Testing the blood.
2011-01-01

... BIOLOGICS ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS Red Blood Cells § 640.14 Testing the blood. Blood from which Red Blood Cells are prepared shall be tested as prescribed in § 610.40 of this chapter and §...

Code of Federal Regulations, 2011

40
Draft Document Concerning the Regulation of Peripheral Blood ...

... For the purpose of this document, peripheral blood stem cell products are defined as hematopoietic cells derived from peripheral blood to be ...

Center for Biologics Evaluation and Research (CBER)

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
41
Compliance Program

Page 1. 1 Compliance Program Guidance Manual Chapter 42 - Blood and Blood Products Inspection of Licensed and Unlicensed Blood Banks ...

Center for Biologics Evaluation and Research (CBER)

42
Blood Grouping and Phenotyping Reagents

... Blood Grouping and Phenotyping Reagents. -. Resources for You. ... Blood Grouping and Phenotyping Reagents. -. Licensed Product Approval Information. ...

Center for Biologics Evaluation and Research (CBER)

43
Cambridge Biotech HIV-1 Western Blot Kit

... Blood & Blood Products; Approved Products; Licensed Products (BLAs); Blood Donor Screening; Infectious Disease Tests. -. Cambridge Biotech HIV-1 Western Blot Kit ...

Center for Biologics Evaluation and Research (CBER)

44
April 28-29, 2011: Blood Products Advisory Committee ...

... April 28-29, 2011: Blood Products Advisory Committee Meeting Transcripts. -. Transcripts. April 28, 2011: Blood Products ...

Center for Biologics Evaluation and Research (CBER)

45
2009 Meeting Materials of the Blood Products Advisory Committee

... July 20-21, 2009: Blood Products Advisory Committee Meeting Presentations. -. -. April 1-2, 2009 Meeting of the Blood Products Advisory Committee. ...

Center for Biologics Evaluation and Research (CBER)

46
21 CFR 640.17 - Modifications for specific products.
2011-01-01

...STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS Red Blood Cells § 640.17 Modifications for specific products. Red Blood Cells Frozen: A cryophylactic substance may be added to the Red Blood Cells for extended manufacturers' storage at...

Code of Federal Regulations, 2011

47
Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
2009-09-16

The modified intra-cerebral challenge assay for acellular pertussis vaccines is used in Japan, Korea, China and possibly other Asian countries as the potency assay for routine release of acellular pertussis (aP) and combination vaccines. National reference standards, typically of whole cell pertussis (Pw) vaccine, are in use in these countries, but there ...

PubMed

48
STIMULATION OF ERYTHROPOIESIS IN NORMAL ADULT ...
1953-08-20

... explanation. Descriptors : *ERYTHROCYTES, *BLOOD, *ANEMIAS, PRODUCTION, BLOOD PLASMA, STRESS(PHYSIOLOGY). ...

DTIC Science & Technology

49
Perfusionist

... in operating mechanical devices to assist in the conservation of blood and blood products during surgery, and ...

MedlinePLUS

50
EFFECT OF IMMUNIZATIONS ON BLOOD GROUP ...
1966-11-30

... Title : EFFECT OF IMMUNIZATIONS ON BLOOD GROUP ANTIBODY PRODUCTION. Descriptive Note : Progress rept.,. ...

DTIC Science & Technology

51
BK060050 Letter

... This device is intended to aid in the prevention of inadvertent hypothermia during administration of blood, blood products, and other fluids. -. -. ...

Center for Biologics Evaluation and Research (CBER)

52
A new canine model for evaluating blood prosthetic arterial graft interactions.
1991-08-01

Various models have been proposed to examine blood-prosthetic materials interactions in terms of the effect of the prosthetic material on platelet structure and function, blood coagulation and fibrinolysis, and tissue infiltrates (cellular or acellular). In addition, these models have been used to examine the change in the graft ...

PubMed

53
Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in G?i2-deficient mice
2005-07-01

Mice deficient for the inhibitory G protein subunit ?2 (G?i2?/?) spontaneously develop a progressive inflammatory bowel disease resembling ulcerative colitis, and have a T helper 1 (Th1)-dominated immune response prior to onset of colitis, which is further augmented after the onset of disease. The present study was performed to investigate whether the ...

PubMed Central

54
Red blood cell production

... to one part of the body or another. Red blood cells are an important element of blood. ... is carried to and eliminated by the lungs. Red blood cells are formed in the red bone ...

MedlinePLUS

55
Potential Hemolysis in Red Blood Cells Whole Blood

FDA is alerting the healthcare community to the need for vigilance during the examination of leukocyte reduced red blood cell and whole blood products prior to ...

Center for Biologics Evaluation and Research (CBER)

56
The Ratio of Blood Products Transfused Affects Mortality in ...
2007-10-01

... Title : The Ratio of Blood Products Transfused ... in Patients Receiving Massive Transfusions at a ... with coagulopathy and require massive transfusion. ...

DTIC Science & Technology

57
Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.
2011-03-08

In a number of countries, whole cell pertussis vaccines (wcP) were replaced by acellular vaccines (aP) due to an improved reactogenicity profile. Pertussis immunization leads to specific antibody production with the help of CD4(+) T cells. In earlier studies in infants and young children, wcP vaccines selectively induced a Th1 dominated immune response, ...

PubMed

58
Acellular Pertussis Booster in Adolescents Induces Th1 and Memory CD8+ T Cell Immune Response
2011-03-08

In a number of countries, whole cell pertussis vaccines (wcP) were replaced by acellular vaccines (aP) due to an improved reactogenicity profile. Pertussis immunization leads to specific antibody production with the help of CD4+ T cells. In earlier studies in infants and young children, wcP vaccines selectively induced a Th1 ...

PubMed Central

59
Blood conservation in cardiac surgery.
2010-12-01

Cardiac surgery is one of the largest users of blood and blood products--currently estimated at 15% of U.K. blood stocks. While the blood supply could be considered to be the safest it has ever been, there are well recognised risks associated with the transfusion of red cells and ...

PubMed

60
Target Inventory Levels for a Hospital Blood Bank or a Decentralized Regional Blood Banking System.
1979-01-01

The major responsibility of a hospital blood bank (HBB) is to administer the collection, processing, storage and distribution of whole blood and blood products throughout the hospital in a manner which ensures that all blood-related demands are met. In ad...

National Technical Information Service (NTIS)

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
61
21 CFR 640.13 - Collection of the blood.
2011-01-01

...OF HEALTH AND HUMAN SERVICES (CONTINUED) BIOLOGICS ADDITIONAL STANDARDS FOR HUMAN BLOOD AND BLOOD PRODUCTS Red Blood Cells § 640.13 Collection of the blood. (a) The source blood shall be collected as prescribed in § 640.4....

Code of Federal Regulations, 2011

62
21 CFR 606.171 - Reporting of product deviations by licensed manufacturers, unlicensed registered blood...
2011-04-01

...manufacturer of blood and blood components, including Source Plasma; an unlicensed registered blood establishment; or a...and unlicensed blood or blood components, including Source Plasma, if that event meets all the following criteria: (1)...

Code of Federal Regulations, 2011

63
21 CFR 607.40 - Establishment registration and blood product listing requirements for foreign blood product...
2011-04-01

...2010-04-01 true Establishment registration and blood product listing requirements for foreign blood product establishments. 607.40 Section...AND PRODUCT LISTING FOR MANUFACTURERS OF HUMAN BLOOD AND BLOOD PRODUCTS Procedures ...

Code of Federal Regulations, 2011

64
MEDITECH Client Server Blood Bank module v5.6

... Home >; Vaccines, Blood & Biologics >; Blood & Blood Products >; Approved Products. Section Contents Menu. ... MEDITECH Client Server Blood Bank module v5.6. ...

Center for Biologics Evaluation and Research (CBER)

65
42 CFR 493.1271 - Standard: Immunohematology.
2010-10-01

...the D(Rho) type by testing unknown red cells with anti-D (anti-Rho) blood typing reagent. (b) Immunohematological testing and distribution of blood and blood products. Blood and blood product testing and distribution must...

Code of Federal Regulations, 2010

66
42 CFR 414.904 - Average sales price as the basis for payment.
2010-10-01

...of the average wholesale price in effect on October 1, 2003 and is not updated in 2006. (3) Blood and blood products. In the case of blood and blood products (other than blood clotting factors), the payment limits are determined in...

Code of Federal Regulations, 2010

67
Scanning electron microscopy as an analytical tool for the study of calcified intrauterine contraceptive devices
1985-01-01

Within the endometrial cavity intrauterine contraceptive devices (IUDs) become encrusted with cellular, acellular, and fibrillar substances. Scanning electron microscopy was used to study the crust. Cellular material consisted mainly of blood cells and various types of bacteria. The fibrillar material appeared to be fibrin which was omnipresent in the ...

Energy Citations Database

68
Evaluation of endotoxin content of diphtheria-tetanus-acellular pertussis combined (DTaP) vaccines that interfere with the bacterial endotoxin test.
2003-05-16

Applicability of the endotoxin test to diphtheria-tetanus-acellular pertussis combined (DTaP) vaccines was examined. We found some DTaP vaccines that strongly interfered with Limulus amoebocyte lysate (LAL) activity of endotoxin without affecting lethal activity of endotoxin in D-galactosamine-treated mice. LAL activity that was interfered in such vaccines increased apparently ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page